Cyanotech CORP

Cyanotech Corporation amended its promissory note with Skywords Family Foundation, increasing its revolving credit facility to $4.6 million and extending the maturity date to April 2027.

Cyanotech Corporation announced the appointment of Jennifer Miyashiro as its new CFO and detailed the results of its 2025 Annual Meeting of Stockholders, including director elections and auditor ratification.

Cyanotech Corporation amended its promissory note with Skywords Family Foundation, allowing for interest payments in common stock, and renewed the employment agreement with CEO Matthew K. Custer.

Cyanotech Corporation has dismissed Grant Thornton LLP as its independent auditor and engaged BPM LLP for the fiscal year ending March 31, 2025.

Cyanotech Corporation has appointed Jennifer Rogerson as its new Vice President of Finance and Administration, effective September 5, 2024, following the company's annual meeting where directors were elected and other key proposals were approved.

Cyanotech Corporation has amended its promissory note with Skywords Family Foundation, increasing its borrowing capacity to $4 million and extending loan maturity dates.

Cyanotech Corporation reported a significant turnaround in its second fiscal quarter, achieving near break-even net income driven by strong sales growth and improved gross margins, despite ongoing liquidity concerns.

Cyanotech Corporation reported a reduced net loss and improved gross margin for Q1 FY26, but faces significant liquidity challenges and a going concern warning.

Cyanotech reports a 10.6% increase in net sales for Q3 2025, with reduced operating losses compared to the previous year.

Cyanotech Corporation reported a decrease in second-quarter sales and gross profit, while experiencing a slight increase in sales for the first six months of fiscal year 2025, as the company navigates inventory restocking and demand fluctuations.

Cyanotech's first quarter of fiscal year 2025 saw a 15% increase in net sales compared to the same period last year, primarily driven by increased demand for astaxanthin products, though gross profit declined due to higher production costs.

Cyanotech reported a decrease in net sales for both the third quarter and first nine months of fiscal year 2024, driven by lower bulk sales and macroeconomic pressures.

Cyanotech Corporation announced a 5% increase in net sales and a significant reduction in operating and net losses for fiscal year 2025, despite auditors raising substantial doubt about the company's ability to continue as a going concern.

Cyanotech's fiscal year 2024 saw flat sales with a shift towards packaged products, alongside increased operating losses and strategic realignments.

Cyanotech's CFO, Jennifer Miyashiro, was granted 50,000 stock options with an exercise price of $0.29, vesting over three years.

Cyanotech Corporation Director David M. Mulder acquired 50,000 shares of common stock, increasing his beneficial ownership to 203,468 shares.

Cyanotech Corp. Director David L. Vied is set to acquire 50,000 common shares on August 28, 2025, under a Rule 10b5-1 plan.

A Cyanotech Corporation director and 10% owner, Michael A. Davis, plans to acquire 50,000 shares of common stock on August 28, 2025, under a Rule 10b5-1 plan.

Cyanotech Corp's President and CEO, Matthew Keith Custer, acquired 2,075 shares of common stock through the vesting of restricted stock units, increasing his direct common stock holdings to 6,754 shares.

Amy Beth Nordin, VP, HR, and Secretary of Cyanotech Corporation, converted 1,502 restricted stock units into common stock and had 525 shares withheld for tax liabilities.

Cyanotech Corporation has announced its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and executive compensation frequency, while reporting ongoing net losses and negative shareholder returns.

Cyanotech Corporation announces its 2024 Annual Meeting of Stockholders to be held on August 22, 2024, featuring proposals for director elections, approval of an independent director stock option plan, and ratification of the company's accounting firm.